Exane Asset Management’s Medtronic MDT Stock Holding History

Exane Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-648	Closed	-$50.4K	–	131
2017 Q3	$50.4K	Buy	+648	New	+$53.8K	0.01%	107

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Exane Asset Management's MDT Position: Q4 2017 in Review

Exane Asset Management sold out of Medtronic (MDT) in Q4 2017, closing a stake of 648 shares — an estimated $50.4K sold.

Exane Asset Management first reported a position in MDT in Q3 2017 and held it in 1 quarter. The position peaked at $50.4K in Q3 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

Exane Asset Management reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
Exane Asset Management sold 648 Medtronic shares in Q4 2017, an estimated $50.4K.
Exane Asset Management first reported a position in Medtronic in Q3 2017 and held it in 1 quarter.
Exane Asset Management's Medtronic position peaked at $50.4K in Q3 2017.
1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Exane Asset Management's 13F filing for Q4 2017, filed 8 Feb 2018.